- Eiger BioPharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Business Update
- Eiger BioPharmaceuticals to Participate in Upcoming August 2020 Investor Conferences
- Eiger BioPharmaceuticals, Inc. to Hold Virtual Annual Meeting of Stockholders on June 15, 2020
- Eiger to Present at Jefferies Virtual Healthcare Conference 2020
- Eiger BioPharmaceuticals Announces FDA Acceptance of NDA for Filing with Priority Review of Zokinvy™ (lonafarnib) for Treatment of Progeria and Progeroid Laminopathies
Eiger BioPharmaceuticals Inc (EIGR:NMQ) closed at 11.29, -28.63% below its 52-week high of 15.82, set on Dec 26, 2019.
4.55Mar 16 202015.82Dec 26 2019
Markit short selling activity
|Market cap||330.15m USD|
|EPS (TTM)||-2.68 |
Data delayed at least 15 minutes, as of Aug 14 2020 21:00 BST.